Ovarian Cancer Biomarker Research Act of 2007

H.Res.1022, relating to reducing maternal mortality in US and abroad. H.Res.1131, related to the prevention, screening and treatment of STDs. S.1760/H.R.3267, Healthy Start Reauthorization Act of 2007. H.Con.Res.330, supporting the goals and ideals of National Sexual Assault Awareness and Prevention Month. S. 2141, Advancing FASD Research, Prevention, and Services Act. Comments to FDA regarding off label usage of drugs. Comments to FDA regarding the regulation of thalidomide. S. 21/H.R. 819, Prevention First. S. 2569/H.R. 3689, Ovarian Cancer Biomarker Act. S. 1375, Mother's Act. Funding for Breast and Cervical Cancer Screening, Gynecological Cancer Education (Johanna's Law), Preemie Act, NIH. S. 1810/H.R.3112, Prenatally and Postnatally Diagnosed Conditions Awareness Act. H.R. 5979, Stillbirth Awareness and Research Act of 2008. Comments on Family Medical Leave Act Notice of Proposed Rule Making (2/11/08) related to changes regarding contact between a health care provider and an employer, the new medical form and its contents, and the increased number of medical certifications. S. 2029, Physician Payments Sunshine Act. H.R. 4054 / S. 2347, Prevention through Affordable Access Act. General support for immunizations.

Client expense: Not reported · Firm income: $140,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE

FY 2009 Funding for Ovarian Cancer Department of Defense Research Program FY 2009 Funding for the National Cancer Institute HR 3689 / S 2569 - Ovarian Cancer Biomarkers Research Act Kennedy / Hutchison Omnibus National Cancer Program Improvement Act: draft policy ideas

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2009 Funding for Department of Defense Ovarian Cancer Research Program FY 2009 Funding for the National Cancer Institute HR 3689 / S 2569 Ovarian Cancer Biomarker Research Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3689/S.2569, Ovarian Cancer Biomarker Research Act of 2007; H.R.20/ S.1375, Melanie Blocker Stokes MOTHERS Act; H.R.819/S.21, Prevention First Act; Stillbirth draft legislation; H.R.3267/S.1760, Healthy Start Act; H.R.4055, Medicare Cervical Cancer Screening and Detection Coverage Act; S.2141, Fetal Alcohol Spectrum Disorders and House companion yet to be introduced; S.1042/H.R.583, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act; S. 1576/H.R. 3333, Minority Health Improvement and Health Disparity Elimination Act; H.R. 3014, Health Equity and Accountability Act of 2007; H.R 1237, Cytology Proficiency Improvement Act; H.R 3825, Newborn Screening Saves Lives Act of 2007; medical home.

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R.1014/S.573, HEART for Women Act. H.R.1544/S.907, Gestational Diabetes Act (GEDI). H.R.1738, Colorectal Cancer Early Detection Act. S.5/H.R.3/S.997, Stem Cell Research Enhancement Act. H.R.3689, Ovarian Cancer Biomarker Research Act. S.1011, NICHD name change. Vulvodynia Awarness Campaign. Increased funding for NICHD.

Client expense: Not reported · Firm income: $140,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), President of the U.S., SENATE